05.25.12
Onyx Scientific has appointed Brian Jolly to the UK team as director of European Business Development. Mr. Jolly will be responsible for overseeing the company’s sales effort across Europe. He has more than 25 years of experience serving in a range of technical and commercial roles in specialty chemicals and the wider chemical industry.
Onyx Scientific operates from MHRA and FDA licensed sites in UK and India, and supports pharmaceutical and emerging biotech from medicinal chemistry and preclinical through Phase I-III and large scale commercial API production.
Denise Bowser, commercial director head at Onyx Scientific, said, “We are delighted to have Brian on board as he has a huge amount of commercial experience that will no doubt benefit the company’s continued growth. Although we have clients across the world, the European market remains a key one. It is therefore essential for us to have this level of expertise on the ground to service clients and potential customers.”
Onyx Scientific operates from MHRA and FDA licensed sites in UK and India, and supports pharmaceutical and emerging biotech from medicinal chemistry and preclinical through Phase I-III and large scale commercial API production.
Denise Bowser, commercial director head at Onyx Scientific, said, “We are delighted to have Brian on board as he has a huge amount of commercial experience that will no doubt benefit the company’s continued growth. Although we have clients across the world, the European market remains a key one. It is therefore essential for us to have this level of expertise on the ground to service clients and potential customers.”